SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MorphoSys AG (MOR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Germanecki
To: Germanecki who wrote (410)7/7/2013 10:21:13 PM
From: mcbio1 Recommendation  Read Replies (1) of 421
 
Co-promotion rights in Europe is a pretty big deal IMO. I don't think Genmab has co-promotion rights with Janssen on daratumumab; think they just settled for royalties (but someone correct me if I'm wrong). It is nice to see MorphoSys move to doing deals with much better economics to them.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News